Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
Northrop Grumman (NYSE: NOC) climbed about 3.2% in early trading as investors responded positively to a contract modification update, according to Yahoo Finance.
THE APEX TIMES
THE APEX TIMES
A recent market note points to Nike and General Mills as examples of widely followed brands sitting close to their 52-week lows, a setup that often draws bargain-hunting interest even as investors weigh whether the weakness reflects temporary noise or durable business headwinds.
THE APEX TIMES
A new round of sell-side coverage, circulated through Yahoo Finance’s market-research roundup, again put Mastercard in the spotlight alongside companies tied to AI, healthcare, and industrial demand. The posts did not provide full report details, leaving investors to focus on the themes analysts are using to frame near-term performance.
THE APEX TIMES
The Securities and Exchange Commission announced a settlement with Bank of America’s Merrill Lynch unit over alleged gaps in anti-money laundering monitoring and suspicious transaction reporting.
THE APEX TIMES
A rotation toward defensives has put Berkshire Hathaway in focus, with the conglomerate’s wide earnings base cited as a stabilizing force.
THE APEX TIMES
A new market column argues that Microsoft’s (MSFT) positioning in software and AI makes it a more durable option for long-horizon investors than newly listed SpaceX (SPCX), which is drawing attention as “one of the best AI plays” in analyst chatter.
THE APEX TIMES
After a dramatic market rerating earlier in 2026, Intel’s stock pulled back sharply in the latest session, underscoring how quickly optimism can run into skepticism about manufacturing progress.
THE APEX TIMES
The late-June 2026 resolution includes a US$2.25 million civil penalty and an FTC order aimed at strengthening Amazon’s Fair Credit Reporting Act compliance, raising fresh questions about how big platforms manage sensitive data as AI systems expand access and automation.
THE APEX TIMES
In remarks highlighted by market coverage, Pfizer indicated it is looking at deal-making capacity, even as investors focus on the scale of the turnaround still ahead.
